Bär BM - Search Results

1

Activity of decitabine in pericardial myeloid sarcoma.

Evers D, Bär BMAM, Gotthardt M, van der Velden WJFM. Evers D, et al. Among authors: bar bmam. Int J Hematol. 2018 Aug;108(2):121-122. doi: 10.1007/s12185-018-2470-y. Epub 2018 May 19. Int J Hematol. 2018. PMID: 29779081 No abstract available.

2

Donors' health state the year after peripheral haematopoietic progenitor cell collection: A prospective follow-up study in related and unrelated donors compared to first-time platelet donors.

Bank I, Wiersum-Osselton JC, Van Walraven SM, Netelenbos T, Fechter M, Marijt-van der Kreek T, Bär BM, Van der Bom JG, Brand A. Bank I, et al. Among authors: bar bm. J Clin Apher. 2016 Dec;31(6):523-528. doi: 10.1002/jca.21444. Epub 2016 Jan 27. J Clin Apher. 2016. PMID: 26812941

3

[The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].

Schattenberg AV, van de Wiel-van Kemenade E, Bär BM, Geurts van Kessel AH, van der Maazen RW, de Witte TJ. Schattenberg AV, et al. Among authors: bar bm. Ned Tijdschr Geneeskd. 1996 Oct 19;140(42):2087-91. Ned Tijdschr Geneeskd. 1996. PMID: 8965951 Clinical Trial. Dutch.

4

Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.

Bär BM, Van Dijk BA, Schattenberg A, de Man AJ, Kunst VA, de Witte T. Bär BM, et al. Bone Marrow Transplant. 1995 Dec;16(6):793-9. Bone Marrow Transplant. 1995. PMID: 8750272

5

[Transfusion medicine].

van Dijk BA, Bär BM, Kunst VA, Olthuis H, de Witte T. van Dijk BA, et al. Among authors: bar bm. Ned Tijdschr Geneeskd. 1994 May 28;138(22):1108-12. Ned Tijdschr Geneeskd. 1994. PMID: 8008122 Dutch. No abstract available.

6

Preparation of random donor leukocyte-poor platelets by cytapheresis.

Olthuis HP, Stienstra S, Puylaert CE, Verhagen CM, Bär BM. Olthuis HP, et al. Among authors: bar bm. Transfus Sci. 1993 Apr;14(2):195-7. doi: 10.1016/0955-3886(93)90031-O. Transfus Sci. 1993. PMID: 10148612

7

Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.

Bär BM, Schattenberg A, Mensink EJ, Geurts Van Kessel A, Smetsers TF, Knops GH, Linders EH, De Witte T. Bär BM, et al. J Clin Oncol. 1993 Mar;11(3):513-9. doi: 10.1200/JCO.1993.11.3.513. J Clin Oncol. 1993. PMID: 8445426

8

Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow.

Bär BM, Schattenberg A, De Man AJ, Hoogenhout MJ, Boezeman J, de Witte T. Bär BM, et al. Bone Marrow Transplant. 1992 Jul;10(1):45-52. Bone Marrow Transplant. 1992. PMID: 1515878 Clinical Trial.

9

Reconstitution of antibody response after allogeneic bone marrow transplantation: effect of lymphocyte depletion by counterflow centrifugal elutriation on the expression of hemagglutinins.

Bär BM, Santos GW, Donnenberg AD. Bär BM, et al. Blood. 1990 Oct 1;76(7):1410-8. Blood. 1990. PMID: 2207316 Free article.

10

Continuous intravenous administration of daunorubicin and cytarabine for remission induction of poor risk acute myelogenous leukaemias and myelodysplastic syndromes.

Bär BM, de Witte T, de Pauw BE, Haanen C. Bär BM, et al. Neth J Med. 1990 Feb;36(1-2):19-24. Neth J Med. 1990. PMID: 2314517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page